Avricore Health Inc. (TSXV:AVCR,OTCQB:AVCRF) has launched its campaign on the Investing News Network’s life sciences channel. Avricore Health is currently focussed on the neutraceutical, medical cannabis and endocannabinoid industries. The company is also in development of HealthTab™, a point-of-care screening system that enables patients to monitor themselves, screening for 21 biomarkers of chronic disease. The HealthTab™ system has been certified by Health Canada and is currently in use by doctors, physicians and medical professionals across the country.

In addition to the company’s HealthTab™ platform, Avricore Health also offers an over-the-counter iron supplement called Hema-FerTM that is available at London Drugs stores throughout British Columbia and Alberta. Avricore generated over $400,000 in sales in 2018, a total the company expects to eclipse by more than double in 2019 as it expands into Atlantic Canada and Quebec.

Avricore Health’s company highlights include the following:

  • Global pharmaceuticals market to reach $1.17 trillion by 2021.
  • Focused on serving the nutraceutical, medical cannabis and endocannabinoid industries.
  • Charges $350 for software installation and a monthly fee for the use of the equipment.
  • HealthTab™ can directly measure and monitor the 21 key biomarkers of chronic diseases.
  • Utilizes Abaxis’ Piccolo Xpress® point of care analyzer, which was initially designed by NASA to test the health of its astronauts.
  • Hema-FerTM generated $400,000 in sales in 2018 and has an 81 percent profit margin.
  • Partnerships and agreements in place with FoodRocket, Molecular You Corporation and Emerald Health Therapeutics.
  • Approximately 60 percent of Avricore Health’s shareholders are institutional.
  • Led by a strong board of directors and advisory team.

Click here to see the educational profile for Avricore Health Inc. (TSXV:AVCR,OTCQB:AVCRF) and to request an investor presentation. 

  • Company has received UK Continuing Professional Development (“CPD”) accreditation for its global education platform, Khiron Academy
  • UK medical professionals may now earn CPD credits through Khiron’s medical cannabis education program
  • The Company has entered into a strategic partnership with Cellen Therapeutics, a leader in digital healthcare in the UK, to increase patient access via medical cannabis education
  • As a leading international medical cannabis educator, nearly 1,000 medical professionals in Latin America and the United Kingdom have registered for, or completed, Khiron Academy training

 Khiron Life Sciences Corp. (“Khiron” or the “Company”) (TSXV: KHRN) (OTCQX: KHRNF) ( Frankfurt : A2JMZC), a vertically integrated cannabis leader with core operations in Latin America and Europe is pleased to announce it has received UK Continuing Professional Development (“CPD”) accreditation for Khiron Academy, the Company’s global medical cannabis education platform.

Additionally, following its accreditation, the Company has entered into a strategic partnership with Cellen Therapeutics, a leader in digital healthcare in the UK and fellow founding member of Project Twenty21, to increase patient access through medical cannabis education initially. Khiron Academy will be made available to prescribers in the UK that have registered with Cellen’s MedCanHub, an emerging education portal. Cellen is market leader, widely recognized for also launching the UK’s first digital pain clinic, Leva.

Keep reading... Show less

TRACE’s plant-based and alkaline wellness products to expand into key markets of Japan, China and the Philippines

Emerging leader in innovative health and wellness beverages and consumer products, BevCanna Enterprises Inc . ( CSE:BEV , Q:BVNNF , FSE:7BC ) (“ BevCanna ” or the “ Company ”) announces today its anticipated expansion into the Asia Pacific region, through its wholly-owned subsidiary Naturo Group. After completing a comprehensive market, distribution and partner assessment, the Company intends to initially launch its portfolio of TRACE health and wellness products in the key markets of Japan, China, and the Philippines, through multi-channel distribution outlets including e-commerce, retail, and wholesale.

Keep reading... Show less

Trulieve acquires dispensary permits from Solevo Wellness West Virginia LLC for $650,000

Trulieve Cannabis Corp . (CSE: TRUL) (OTCQX: TCNNF), a leading and top-performing cannabis company in the United States and the largest cannabis company in Florida announced today that it acquired Solevo Wellness West Virginia LLC (“Solevo”) and its three West Virginia dispensary permits for $650,000 . Solevo was awarded two permits in Morgantown and one in Parkersburg in January 2021 as part of the West Virginia application process.

Keep reading... Show less

Better Plant Sciences Inc. (CSE: PLNT) (OTCQB: VEGGF) (FSE: YG3) (“Better Plant”) or (the “Company”) a wellness company that develops and sells sustainable, plant-based products, is pleased to announce that it’s Jusu Home and Body line is now available for purchase on Faire Wholesale Marketplace (“Faire” or “www.faire.com”), an online wholesale marketplace valued at US $2.5 billion. Jusu Home and Body products are currently featured in their “New Arrivals” section.

Cannot view this image? Visit: https://orders.newsfilecorp.com/files/6377/80230_8c77c54544bf884c_001.jpg

Keep reading... Show less

 Aion Therapeutic Inc. (CSE: AION) (” Aion Therapeutic ” or the ” Company “) today announced that it has retained KCSA Strategic Communications (” KCSA “), a leading New York City -based communications firm.

Keep reading... Show less